Angiotensin II receptor antagonist reduces urinary liver-type fatty acid-binding protein levels in patients with diabetic nephropathy and chronic renal failure

MeSH terms

• Angiotensin Receptor Antagonists*
• Angiotensin-Converting Enzyme Inhibitors / therapeutic use*
• Benzimidazoles / therapeutic use*
• Benzoates / therapeutic use*
• Creatinine / blood
• Diabetic Nephropathies / drug therapy
• Diabetic Nephropathies / urine*
• Fatty Acid-Binding Proteins / urine*
• Glomerular Filtration Rate
• Humans
• Kidney Failure, Chronic / drug therapy
• Kidney Failure, Chronic / prevention & control
• Kidney Failure, Chronic / urine*
• Telmisartan